BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17027336)

  • 1. Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!
    Lainscak M; Doehner W; Anker SD
    Eur J Heart Fail; 2007 Jan; 9(1):2-3. PubMed ID: 17027336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of testosterone on insulin sensitivity in men with heart failure.
    Malkin CJ; Jones TH; Channer KS
    Eur J Heart Fail; 2007 Jan; 9(1):44-50. PubMed ID: 16828341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and heart failure.
    Malkin CJ; Channer KS; Jones TH
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):262-8. PubMed ID: 20404724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic heart failure as a metabolic disorder.
    Anker SD; Al-Nasser FO
    Heart Fail Monit; 2000; 1(2):42-9. PubMed ID: 12634873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy: treatment of metabolic disturbances in heart failure.
    Naghi JJ; Philip KJ; DiLibero D; Willix R; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):14-23. PubMed ID: 21097668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myths and truths of growth hormone and testosterone therapy in heart failure.
    Nguyen CT; Aaronson A; Morrissey RP; Agarwal M; Willix RD; Schwarz ER
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):711-20. PubMed ID: 21714602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.
    Iellamo F; Volterrani M; Caminiti G; Karam R; Massaro R; Fini M; Collins P; Rosano GM
    J Am Coll Cardiol; 2010 Oct; 56(16):1310-6. PubMed ID: 20888520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
    Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.
    Chaggar PS; Malkin CJ; Shaw SM; Williams SG; Channer KS
    Cardiovasc Ther; 2009; 27(3):187-93. PubMed ID: 19689618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance: a potential new target for therapy in patients with heart failure.
    Wong AK; AlZadjali MA; Choy AM; Lang CC
    Cardiovasc Ther; 2008; 26(3):203-13. PubMed ID: 18786090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone and testosterone in heart failure therapy.
    Agarwal M; Naghi J; Philip K; Phan A; Willix RD; Schwarz ER
    Expert Opin Pharmacother; 2010 Aug; 11(11):1835-44. PubMed ID: 20486829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
    Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
    Malkin CJ; Pugh PJ; West JN; van Beek EJ; Jones TH; Channer KS
    Eur Heart J; 2006 Jan; 27(1):57-64. PubMed ID: 16093267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic Deficiencies in Heart Failure: Ready for Prime Time?
    Napoli R; D'Assante R; Miniero M; Salzano A; Cittadini A
    Heart Fail Clin; 2020 Jan; 16(1):11-21. PubMed ID: 31735309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does growth hormone play a role in chronic heart failure?
    Volterrani M; Giustina A; Lorusso R; Giordano A
    Heart Fail Monit; 2002; 3(2):60-4. PubMed ID: 12634881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone deficiency: a risk factor for cardiovascular disease?
    Jones TH
    Trends Endocrinol Metab; 2010 Aug; 21(8):496-503. PubMed ID: 20381374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy in heart failure.
    Arcopinto M; Salzano A; Isgaard J; Cittadini A
    Curr Opin Cardiol; 2015 May; 30(3):277-84. PubMed ID: 25807222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone resistance in chronic heart failure and its therapeutic implications.
    Cicoira M; Kalra PR; Anker SD
    J Card Fail; 2003 Jun; 9(3):219-26. PubMed ID: 12815572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
    Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal alterations in heart failure: anabolic impairment in chronic heart failure - diagnostic, prognostic and therapeutic issues.
    Arcopinto M; Cittadini A
    Front Horm Res; 2014; 43():57-69. PubMed ID: 24943298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.